Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1975-12-29
1977-07-19
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
260244R, A01N 900, A01N 922, C07D26500, C07D27300
Patent
active
040369609
ABSTRACT:
Compounds of the formula ##STR1## wherein X is halogen of atomic number 9 through 35, i.e., fluorine, chlorine or bromine, or alkyl of 1 to 3 carbon atoms, n is 0, 1 or 2, and R and R.sup.1 are individually hydrogen, methyl or ethyl, possess acarid ovicidal activity.
REFERENCES:
patent: 3542774 (1970-11-01), Shavel et al.
patent: 3743641 (1973-07-01), Makula et al.
patent: 3880847 (1975-04-01), Boshagen
Chem. Abst. 59, 2806(e) (1963)-Kurihara et al., "4-Oxo-2,3dihydro-5,6-benz-1,3-oxazine derivatives".
Buchanan, Jr. J. A.
Chevron Research Company
DeJonghe T. G.
Meyers Albert T.
Newell Dix A.
LandOfFree
1,3-Benzoxazin-4-one derivatives and their use as ovicides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-Benzoxazin-4-one derivatives and their use as ovicides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-Benzoxazin-4-one derivatives and their use as ovicides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2293505